Latest

pharamcology

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·5 min read

A new antiviral drug heading into clinical trials offers hope for COVID-19

EIDD-2801, a new antiviral drug, has the potential to treat coronavirus. A new study reveals the drug can prevent severe lung injury in mouse models and cultured human lung cells infected with COVID-19. The drug will soon be ready for human testing.

Featured Neuroscience Open Neuroscience Articles

·January 11, 2019·5 min read

Sleeping Though a Fire Alarm: Benzodiazepines Prevent Ability to Wake in Response to Threat

Researchers report popular benzodiazepine sleep medications, such as Ambien and Halcion, caused test subjects to sleep through fire alarm drills. However, a newly developed class of sleeping medications perverse the ability to wake in response to threat.

Featured Neurology Open Neuroscience Articles

·January 4, 2019·4 min read

Botox Reduces Chronic Migraine Attacks

According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.

Brain Cancer Featured Neurology

·November 27, 2017·7 min read

Cancer Drug Starts Clinical Trials in Human Brain Cancer Patients

A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.

Autism Featured Neuroscience Psychology

·May 15, 2017·4 min read

Diabetes Drug May Help With Symptoms of Fragile X

Researchers report a common diabetes drug helped to restore protein production in the brain to normal levels and repaired brain connections in mouse models of Fragile X.

Image shows a brain scan from a glioblastoma patient.

Brain Cancer Featured Neurology Open Neuroscience Articles

·April 14, 2017·6 min read

Immunotherapy for Glioblastoma Well Tolerated and Increases Survival

Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 4, 2017·3 min read

Low Doses Penicillin in Early Life Induces Long Term Behavioral Changes

A new study reports penicillin when administered during pregnancy or during early years of life can result in long-term behavioral changes.

Image shows the outline of a person and their lungs in blue.

Featured Neurology Open Neuroscience Articles

·February 26, 2017·5 min read

Dietary Supplement Shows Promise In Treatment of Sleep Apnea

Researchers report Yohimbine, a dietary supplement derived from tree bark, shows potential in the treatment of sleep apnea, especially for those with anxiety disorders and high blood pressure.

Brain Cancer Featured Neuroscience Open Neuroscience Articles Psychology

·December 1, 2016·4 min read

Hallucinogenic Psilocybin Offers Relief For Cancer Related Depression and Anxiety

According to researchers, a single large dose if psilocybin, the active hallucinogenic compound found in magic mushrooms, helped provide relief for people suffering from cancer related depression and anxiety for up to six months.

Featured Neuroscience Psychology

·September 9, 2016·5 min read

Researchers Outline Barriers to Treating Fear and Anxiety

A new study offers insight into the neurological processes involved in fear and anxiety.

Image shows a man holding his head in pain.

Featured Neurology

·June 8, 2016·4 min read

New Drug to Prevent Migraine May Start to Work in Days

A new study reports a novel drug designed to treat migraine was associated with fewer headache hours for sufferers within 3 to 7 days following their first injection.